This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The events of 2020 will forever impact immune health's future. We've pulled together the market data, proprietary surveys, and investment tracking into a report that calls out the new era in immunity.
Regulatory uncertainty. Class-action lawsuits. Investor impatience. COVID-19 distractions. All that, and now a coalition of drug warriors and major CPG brands enters the frothy CBD discussion. Are its motives to build the business—or shut it down?
As COVID-19 continues to disrupt the conventional food supply, natural products brands have found ways to support distributors, customers and consumers.
The novel coronavirus sprung out of China, but now the spread has disrupted manufacturing and logistics around the globe. Iowa farmer Andrew Pittz says it's time to bring the supply chain home.
CBD brands often point to hemp as a cash crop that can help keep family farms solvent, but other say that the agricultural economics will favor farmers who already have the equipment and capital. A looming glut in raw material may also doom early...
In a piece for Nutrition Business Journal's recently published Hemp & CBD Guide 2.0, Council for Responsible Nutrition President and CEO Steve Mister shared the top concerns CBD poses for the supplement industry.
That problems with purity and potency in CBD products haven't gotten much notice from consumers doesn't mean those problems aren't going to emerge as an issue. Matthew Kind talks about CannaInsider's Transparency Badge as one solution.
An FTC official signaled his agency will take more aggressive enforcement action against marketers of CBD in the future, moving beyond warning letters and instead issuing civil investigative demands.